E Fund Management Co., Ltd.

SEC CIK: 0001842296
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overview All 13F holders of CRVS Full Q2 2026 holdings

Shares (Q2 2026): 11,491
Value: $171.7K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of CRVS by E Fund Management Co., Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	11,491	$171.7K	<0.1%	−2,665−18.8%	Reduced	Holders
Q1 2026	14,156	$207.1K	<0.1%	–	No prior filing	Holders